Busulfan
NDC 25021-241, Busulfan, injection, solution, concentrate, from Sagent Pharmaceuticals.
- Product NDC
- 25021-241
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207050
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUSULFAN6 mg/mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-241-10 | 25021024110 | 8 VIAL in 1 CARTON (25021-241-10) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/086a715e-4958-4bb5-9ebd-86171e6b6203Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-241
Use it
Look up 25021-241 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-241. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.